Moreover, a group of researchers has recently studied the effect of F16 in an in vitro and in vivo model of GBM, showing that inhibition of VEGFR by F16 delayed tumor growth by reducing angiogenesis and reduced the processes of migration and invasion [42]. This evidence concerns the gene KDR and glioblastoma.